Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, November 3, 2026

Back to today

TWLO Q3 FY12/26 Earnings Review

Twilio's Q3 revenue rose 20% to $1.56 billion, but Q4 organic growth guidance fell to 11% to 12% and RPO declined 28%.

TWLO $31B
Cestrian Capital Research 3 clicks

From X

@aleabitoreddit 1 click

Serenity on X

The rhetoric on X and from Elon leans overwhelmingly apocalyptic on Democrats winning. It's a mini bubble here, but I think people forget AI is bipartisan national security priority, and that $NVDA's historic rally + AI buildout acceleration happened under the Biden admin. Anyone can extrapolate a politician's negative view on AI to doompost indexes or that " $CRWV is going to go down". But in all reality, even with a Democratic governor, we'll likely just see some headwinds to individual developers, and incentives like "clean-energy tax credits" moving to other areas in AI like solar manufacturing. Rather than any market-wide doomsday scenario that the opposing party likes to portray. Even Bitcoin/Ethereum performed better under the negatively perceived regulation of Gary Gensler. Just like any major event, everyone looks at the worst case scenario like helium disruption shutting down Samsung, $TSM, and the memory trade... Then markets move on few weeks later.
@StableBread

Fajasy on X

Fuel Tech's $FTEK new CEO used his first earnings release to make acquisitions part of the plan, with $27.8M of cash and investments against a $44M market cap. Ramesh Nuggihalli, a former COO of competitor CECO Environmental $CECO, took over the power plant pollution-control company in August. He's pursuing organic growth in core markets, data center power, and water treatment, plus "select M&A" to add products and sales channels. Its cash and investments come to $0.89/share, ~63% of the $1.42 stock price. So I read the new plan as a choice for the cash: (1) Either it stays the floor under the stock, or (2) it becomes the budget for deals. Q3 revenue rose 16% to $8.7M, and the $267K net loss was its smallest this year (vs. a $303K profit a year ago). But air pollution control (APC) gross margin fell to 40% from 47% a year ago on project mix. APC backlog reached ~$20M with October's $3.3M of awards, but none of this year's awards is a data center order. Q3 also had the year's biggest drop in cash and investments, $1.8M, but receivables rose ~$2.0M as APC projects ramped, so the drop is mostly money customers owe, not money lost. At $1.42/share, $FTEK trades ~19% above its $1.19/share book value and below the $1.72-2.17 sum-of-the-parts in my August 27 deep dive. Would you rather $FTEK spend its cash on a deal or keep it as the floor? I'd rather hear three answers on the November 4 call before giving the new plan credit: 1) M&A: How much of the $27.8M the board would spend, and whether it would pay in cash or in stock trading near book value. 2) Data center: Whether the August talks with a data center customer about paying to reserve $FTEK's capacity are still going. 3) Margins: Whether the ~$20M backlog carries the 40% APC margin from Q3 or the 47% from a year ago.
@ACapitalLP

A Capital on X

The 13% puke today is the market questioning whether $CVI is using peak-cycle earnings to justify a transformative acquisition (nearly doubling nameplate capacity). The $MPC assets may be attractive, but shareholders are absorbing dilution, additional debt, and the risk that refining margins normalize before the company can meaningfully delever… $CVI was always sub-scale, so there’s a legitimate strategic rationale here. The irony is that the best time to buy cyclical assets is usually when you can least afford to finance them…
@StableBread 1 click

Fajasy on X

U.S. inflation is still sticky, and it’s not only the government’s numbers saying so. Inflation shows up in both the government’s price indexes and the price of gold: → Growth × Policy: Core PCE inflation, the PCE price index minus food and energy, rose to 3.1% in September from 3.0% in August, 1.1% above the Fed’s 2% target. CPI inflation rose to 3.7% from 3.4%. I focus on core PCE because the Fed sets its 2% target on the PCE index, and leaving out food and energy, whose prices swing the most, provides a better read on where inflation is headed. → Charles Gave’s Four Quadrants (from Gavekal): At the end of October, an ounce of gold bought 42.5 shares of $IEF (a 7-10 year Treasury ETF) vs. a 7-year average of 26.3. That’s down from 47 at the end of September, since gold fell 6.9% in October while $IEF rose 3.1%. Gave reads gold beating bonds as the currency losing value, and gold has been beating bonds since March 2020. Gave’s framework still places the U.S. in an inflationary boom, where the U.S. has been since November 2023, apart from four weeks in March and April 2026. That’s the quadrant where he favors gold, commodities, real estate, value stocks, emerging markets and cyclicals with high fixed costs, and avoids long-duration bonds. These assets either rise in price with inflation or earn more when the economy runs hot, while long-duration bonds pay a fixed amount that inflation eats away. High Treasury yields don’t change that call, since Gave’s gold/IEF ratio divides the gold price by $IEF’s total return (interest included), and the ratio is still 61% above its 7-year average even after October.

Investor Letters

All letters

Stevanato down 30%. Yikes.

Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3…

STVN $5.4B
Best Anchor Stocks 3 clicks

Marvellous Value Destruction

Marvell’s proposed Lumentum deal risks alienating Cloudlight customers and losing engineering talent, despite limited optical integration…

LITE $62B
Irrational Analysis 2 clicks

FTAI Aviation Update, Part Two

FTAI Aviation’s $234 million Jereh JV deposit funds Power inventory, while customer concentration, lower cash guidance and pending U.S.

FTAI $20B
CV's Substack 4 clicks
KRYS · short

Krystal Biotech INC

Krystal Biotech is a profitable commercial-stage biotech with an $8.7 billion enterprise value and one FDA-approved topical gene therapy,…

KRYS $9.2B
Value Investors Club

The Mispriced Assets Super Bowl

Groupon, Corsair and StepStone report within 15 minutes, setting up volatility between Groupon’s after-hours release and its Friday morning…

STEP $5.3B
Mispriced Assets

Coupang: 2Q26 Business Recap

Coupang’s product-commerce revenue rose 8% in constant currency as data-leak churn lingered, while promotions and underused logistics…

CPNG $27B
Speedwell Memos 8 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 73 of 273

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

321 firms

Sectors

Ordered by how often our editor reaches for them.